Interpace Diagnostics Corporation
Parsippany, NJ, US· latest recorded location
INTERPACE DIAGNOSTICS CORPORATION is named on 10 US grants and 15 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 10
- Published applications
- 15
- Inventors
- 21
- Granted in 2026 so far
- 0
- Most recent grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 2 | 5 |
| 2020 | 1 | 2 |
| 2021 | 2 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Technology areas
Share of 25 documents
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17
- A61BMedical diagnosis and surgery6
- A61NElectrotherapy6
- G01NInvestigating or analysing materials by determining their chemical or physical properties6
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or4
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the2
- Y02ATechnologies for adaptation to climate change2
- A61KMedicines and medical preparations1
- A61PTherapeutic uses of medicines1
- C12NMicroorganisms or enzymes1
Recent patents
- Methods for treating Barrett's metaplasia and esophageal adenocarcinoma21 Jan 2025US 12,205,676 B2
- Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions12 Oct 2021US 11,143,657 B2
- miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms14 Sep 2021US 11,118,231 B2
- Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease19 May 2020US 10,655,184 B2
- Methods for measuring carcinoembryonic antigen15 Oct 2019US 10,444,239 B2
- Methods for treating barrett's metaplasia and esophageal adenocarcinoma13 Nov 2025US 2025/0349390 A1
- Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms19 Dec 2024US 2024/0417811 A1
- Mirnas as biomakers for distinguishing benign from malignant thyroid neoplasms7 Jul 2022US 2022/0213551 A1
- Methods for measuring carcinoembryonic antigen6 Aug 2020US 2020/0249236 A1
- Methods for treating barrett's metaplasia and esophageal adenocarcinoma30 Jan 2020US 2020/0035324 A1
Most cited
By later US patents